PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
May 16, 2014BloodOpen Access

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti–IL-6) in multiple myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJesús F. San MiguelJBJoan BladéOSOfer Shpilberg

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miguel et al. (2014) studied this question.

synapsesocial.com/papers/6a21e6aff5119ebe07a60247https://doi.org/10.1182/blood-2013-12-546374
View Full Paper
Ask AI
Bookmark
Share